Quantitative analysis for Prelude Therapeutics Incorporated (PRLD) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (69.0) (grade B). 29 signals analyzed (24 differentiated alt-data).
PRLD stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $4.76 | $4.17 | $4.39 |
| 2026-05-08 | $5.32 | $4.79 | $4.86 |
| 2026-05-20 | $4.54 | $4.12 | $4.50 |
| 2026-06-02 | $3.76 | $3.47 | $3.50 |
| 2026-06-12 | $4.52 | $3.97 | $4.49 |
| 2026-06-25 | $4.40 | $4.02 | $4.10 |
| 2026-07-08 | $5.28 | $4.88 | $5.12 |
| 2026-07-20 | $4.32 | $3.95 | $4.06 |
| 2026-07-30 | $5.13 | $4.71 | $5.05 |
| 2026-08-12 | $5.90 | $5.39 | $5.73 |
| 2026-08-24 | $6.83 | $6.12 | $6.47 |
| 2026-09-03 | $5.62 | $5.11 | $5.25 |
How Prelude Therapeutics Incorporated stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| CGEN | Compugen Ltd. | $256M | — |
| ACHV | Achieve Life Sciences, Inc. | $244M | 42.0 |
| PRE | Prenetics Global Limited | $261M | — |
| PMI | Picard Medical, Inc. | $240M | — |
View all Health Care stocks by valuation and signals →
Prelude Therapeutics Incorporated (PRLD) scores Buy (69.0), with no measured dimension below 51. Its highest are competitive moat at 87, valuation at 72, analyst consensus at 61, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 87 |
| valuation | 72 |
| analyst consensus | 61 |
| technicals | 53 |
| earnings quality | 51 |
StoQuant analyzes 29 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Prelude Therapeutics Incorporated (PRLD): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/PRLD"><img src="https://stoquant.com/badge/PRLD.svg" alt="Prelude Therapeutics Incorporated (PRLD) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.